Teva Pharmaceuticals USA is recalling several lots of Losartan Potassium tablets (25 mg, 50 mg, and 100 mg) used to treat high blood pressure. The recall was initiated because an impurity called N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) was detected in the active ingredient used to make the tablets. These specific products were distributed in bulk to a re-packager and are identified by the NDC codes 0591-3745-00, 0591-3746-00, and 0591-3747-00. Consumers currently taking this medication should not stop use without consulting their doctor, as the risk of stopping the medication suddenly may be higher than the risk of the impurity.
The tablets contain a chemical impurity (NMBA) that was detected during testing of the active pharmaceutical ingredient. NMBA is classified as a potential human carcinogen, meaning long-term exposure could potentially increase the risk of cancer.
Contact healthcare provider and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.